PROGRAM OVERVIEW

The NLA is excited to share that we will host our first-ever virtual Scientific Sessions! Due to current travel restrictions and gathering limitations in the city of Chicago, the NLA has made the difficult decision to rescope our 2020 Scientific Sessions into a fully virtual conference held live on Thursday, December 10 – Saturday, December 12, 2020.

There will be a reduced meeting registration for the virtual conference at a discounted rate of only $299.  Registration for the virtual sessions will open at the end of August.

If you are currently registered for the live 2020 NLA Scientific Sessions:
Please reach out to meetings@lipid.org to let us know if you would like to transfer your registration to the virtual conference (and receive a refund for the difference in cost) or receive a full refund if you are unable to attend.  If we haven’t heard from you by Friday, September 5, 2020 we will automatically transfer your registration to the virtual conference and refund you the difference in the registration fee.  

If you booked a hotel room at the host hotel, the Chicago Marriott Magnificent Mile:
All hotel reservations made at our host hotel, Chicago Marriott Magnificent Mile, will be automatically cancelled on Monday, August 24th and refunded via your original method of payment within 30 days.   

Please continue to monitor this page for updates.

You may need to disable administrative overlay in your Drupal record

Edit Parent - PROGRAM (visibility Show)

Agenda


*PLEASE NOTE* The Conference will be held using the CENTRAL time zone.
Thursday, December 10, 2020
10:00AM - 11:25AM Session I- Cardiovascular Preventive Care in Pregnancy

10:05AM - 10:25AM

Pregnancy and Contraception - How Should we Counsel Women with Severe Dyslipidemia? Jennifer L.  Thompson, MD
10:25AM - 10:45 AM Medical Therapy during Pregnancy Pamela B. Morris, MD, FNLA*
10:45AM - 11:05 AM Medical Nutrition Therapy During High Risk Pregnancy with Severe Hypertriglyceridemia Wahida Karmally, PhD, MS, RDN, CDE, CLS
11:05AM - 11:25AM Post Session Assessment and Question & Answer Panel
11:25AM - 11:30 AM Break
11:30AM - 1:15 PM Session II- Ethical Dilemmas in Lipidology
11:30AM - 11:35AM Pre-Session Assessment
11:35AM - 11:55 AM CVD Risk Reduction – Is Ovum Selection Ethical for FH? James A. Trippi, MD, FNLA*
11:55AM - 12:15PM Can we Justify FH Genetic Testing Prior to the Age of Consent? G. Kevin Donovan, MD, MA
12:15PM - 12:35PM Statins and Reproductive Health in Teens - An Accident Waiting to Happen? Ann Liebeskind, MD, FNLA*
12:35PM - 12:55PM Does Cholesterol Screening Potentially Limit Job Opportunities? Don P. Wilson, MD, FNLA*
12:55PM - 1:15PM Post Session Assessment and Question & Answer Panel
1:15PM - 2:00PM Break
2:00PM - 3:30PM

CME/CE Symposium- Bridging the Gaps in Management of Familial Chylomicronemia Syndrome: A Team-Based Patient-Focused Approach hosted by the National Lipid Association
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2020 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.

4:00PM - 6:00PM NLA Opening Session – Impact of Genetics on Clinical Practice- Chair Dr. Christie Ballantyne
4:00PM - 4:05PM Pre-Session Assessment  
4:05PM - 4:15PM Case Presentation Aliza Hussain, MD
4:15PM - 4:35PM Genetic Testing for Lipid Disorders Zahid Ahmad, MD
4:35PM - 4:55PM Polygenic Risk Scores for CVD, Use in Practice and Potential Impact on Healthcare Joshua W. Knowles, MD
4:55PM - 5:15PM My Patients are Ordering Direct-to-Consumer Genetic Testing- What Now? Emily E. Brown, MGC, CGC
5:15PM - 5:35PM Genetics and Biotech therapies Christie M. Ballantyne, MD, FNLA*
5:35PM - 5:40PM Post Session Assessment
5:40PM - 6:00PM Question & Answer Panel
6:00PM - 7:00PM NLA Virtual Honors and Awards Ceremony
7:00PM - 8:30PM CME/CE Symposium- Dialogues from the Dais: Lipid Management in Clinical Medicine hosted by Medtelligence
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2020 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
Friday, December 11, 2020
7:00AM - 9:00AM CME/CE Symposium- The Ever-Evolving Treatment Landscape of Lipid-Lowering Therapies hosted by Medscape
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2020 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
8:00AM - 8:50AM Abstract Author Q&A in Virtual Poster Hall / Exhibit Hall
8:50AM - 9:00AM Opening Remarks
9:00AM - 10:25AM Session III- Non-Alcoholic Fatty Liver Disease and Risk of Cardiovascular Disease: What Clinicians Need to Know
9:00AM - 9:05AM Pre-Session Assessment
9:05AM - 9:15AM Case Presentation of Patient with Non-Alcoholic Fatty Liver Disease Pam R. Taub, MD
9:15AM - 9:35AM Diagnosing NAFLD and NASH in Clinical Practice and When to Refer to a Specialist John M. Vierling, MD
9:35AM - 9:50AM Evidence Based Drug Therapy Treatment Options for NAFLD Michael Wilkinson, MD
9:50AM - 10:10AM Lifestyle Interventions for NAFLD: Evaluation of the Evidence Lisa B. VanWagner, MD, MSc
10:10AM - 10:25AM Post Session Assessment and Question & Answer Panel
10:25AM - 10:30AM Break
10:30AM - 10:55AM NLA Presidents Address
10:55AM - 11:30AM W. Virgil Brown Distinguished Award and Lectureship John R. Guyton, MD, FNLA
11:30AM - 12:05PM Exhibit Hall
12:05PM - 1:30PM Session II- Imaging Atherosclerosis: What We Know and Gaps in Knowledge
12:05PM - 12:10PM Pre-Session Assessment
12:10PM - 12:30PM Cardiac CT in 2020 Matthew J. Budoff, MD
12:30PM - 12:50PM Carotid Ultrasound and Brachial FMD James H. Stein, MD
12:50PM - 1:10PM Imaging in Pediatrics- Where we Are and Where we Need to go Elaine M. Urbina, MD, MS
1:10PM - 1:30PM Post Session Assessment and Question & Answer Panel
1:30PM - 2:40PM Exhibit Hall
1:30PM - 2:30PM Expert Theaters
2:40PM - 4:05PM Session V- Let’s Talk About Sex…Hormones
2:40PM - 2:45PM Pre-Session Assessment
2:45PM - 3:05PM Hormone Replacement in Postmenopausal Women: Panacea or Poison? Eliot A. Brinton, MD, FNLA
3:05PM - 3:25PM Testosterone Treatment in Men Maamoun Salam, MD
3:25PM - 3:45PM Effects of Hormonal Therapy for Transgender Transition Eugenia Gianos, MD, FNLA
3:45PM - 4:05PM Post Session Assessment and Question & Answer Panel
4:05PM - 4:15PM Break
4:15PM - 5:40PM Session VI- Prevention of Atherosclerotic Cardiovascular Disease in South Asians in the US
4:15PM - 4:20PM Pre-Session Assessment
4:20PM - 4:40PM Epidemic of ASCVD in South Asians in the US and Strategies for Early Identification Dinesh Kalra, MD
4:40PM - 5:00PM Diabetes and Heart Disease in South Asians in the US:  Challenges and Opportunities in Management Krishnaswami Vijayaraghavan, MD, MS, FNLA
5:00PM - 5:20PM Dyslipidemia in South Asians in the US Nihar R. Desai, MD, MPH
5:20PM - 5:40PM Post Session Assessment and Question & Answer Panel
6:00PM - 7:15PM CME/CE Symposium- Genetic Dyslipidemias- Familial Hypercholesterolemia and Beyond hosted by the National Lipid Association
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2020 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
7:30PM - 8:30PM New Member & Women in Lipidology Event
Saturday, December 12, 2020
7:00AM - 9:00AM CME/CE Symposium- Mastering the Management of Hyperlipidemia in Statin-Treated or Statin-Intolerant Patients: Recent Treatment Advances for Patients That Remain at High-Risk of ASCVD hosted by the National Lipid Association
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2020 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
8:00AM - 8:50AM Exhibit Hall
8:50AM - 9:00AM Opening Remarks
9:00AM - 10:10AM Session VII
9:00AM - 10:10AM TBD TBD
10:10AM - 11:00AM Abstract Author Q&A in Virtual Poster Hall / Exhibit Hall
11:00AM - 11:50AM Session VIII- Abstract Award Presentations
11:50AM - 12:20PM NLA & MWLA News and Notes/ Abstract Awards
12:20PM - 1:30PM Exhibit Hall
12:20PM - 1:20PM Expert Theaters
1:30PM - 3:00PM Special Non-CME Joint Session between EAS and NLA- Dyslipidemia Treatment in Light of the New Guidelines- Chairs: Lale Tokgözoğlu, MD and Antonio M. Gotto, Jr., MD, DPhil, FNLA
1:30PM - 1:35PM Session Introduction from Chairs  
Targets and Goals
1:35PM - 1:50PM EAS Perspectives Alberico L. Catapano, PhD
1:50PM - 2:05PM NLA Perspectives Carl E. Orringer, MD, FNLA
Therapeutic Approaches
2:05PM - 2:50PM EAS Recommendations & Perspectives Lale Tokgözoğlu, MD
2:50PM - 2:35PM NLA Recommendations & Perspectives Peter H. Jones, MD, FNLA
2:35PM - 3:00PM Question & Answer Panel
3:00PM - 3:05PM Break
3:05PM - 4:05PM Session VII- Scientific Statements
3:05PM - 3:10PM Introduction of the NLA Scientific Statement on CAC Matthew J. Budoff, MD
3:10PM - 3:30PM NLA Scientific Statement on CAC: CAC Testing and Interpretation Matthew J. Budoff, MD
3:30PM - 3:50PM NLA Scientific Statement on CAC: CAC Guided Treatment Recommendations and other Considerations Michael Blaha, MD
3:50PM - 4:05PM Question & Answer Panel
4:05PM - 4:25PM Junior Faculty Research Award Presentation Nathan Stitziel, MD, PhD
4:25PM - 4:30PM Break
4:30PM - 5:00PM Late Breakers

 

Ancillary Courses


Foundations of Lipidology Course

Pre-conference Course

Thursday, November 19 • 8:00 am–5:35 pm

Friday, November 20 • 8:00 am–2:30 pm

$550 NLA Members, $950 Non-Members, $0 Trainees

 

Overview

The NLA's Foundations of Lipidology course provides an introductory review of the core curriculum in Clinical Lipidology. This course is designed for any healthcare professional seeking to learn the fundamentals of Lipidology. Experts in Lipidology will lecture on basic concepts and guide participants through interactive learning scenarios that provide the knowledge and tools necessary to work effectively in a lipid practice and prepare for advanced training.

This course is particularly useful to review core elements of Clinical Lipidology and is appropriate for clinicians from the full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Pharmacist, Exercise Physiologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into Lipidology.

The Foundations of Lipidology is offered as a two-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

Masters in Lipidology Course

Pre-conference Course

Thursday, December 3 • 7:30 am–5:40 pm

Friday, December 4 • 7:30 am–2:20 pm

$750 NLA Members, $1,250 Non-Members, $395 Trainees

 

Overview

The NLA's Masters in Lipidology course provides an advanced examination of the core curriculum in Clinical Lipidology. This course is designed for any health care professional with experience in Lipidology who desires advanced training. Experts in the field of Lipidology will lecture on advanced concepts and guide participants through interactive learning scenarios that provide tools and skills to further advance personal standards of practice. It is recommended that attendees have already completed preparatory coursework (e.g., Foundations of Lipidology or similar core curriculum training).

This course is particularly useful to explore the details of Clinical Lipidology and is appropriate for clinicians from the full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Exercise Physiologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into Lipidology.

Masters in Lipidology is offered as a two-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

For additional information, click the course logo below.

For additional information, click the course logo below.

Accreditation Information


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.25 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this Other activity (Annual Meeting Simulive Virtual Conference) for a maximum of 15.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 15.00 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

Pharmacist Accreditation Statement

Universal Activity Number JA0007192-0000-20-005-H01-P (Application)
This Activity has been approved for 15.25 contact hour(s) (1.525 CEUs) of the Accreditation Council for Pharmacy Education

Nursing
The maximum number of hours awarded for this CE activity is 15.2 contact hours.

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

 

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses, and registered dietitians with an interest in lipid management.

Type of Activity
Live Activity, Application

Educational Objectives

At the conclusion of this activity, all participants should be able to:

  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team.

Session I: Cardiovascular Preventive Care in Pregnancy

  • Discuss potential cardiovascular risks associated with pregnancy in women with genetic dyslipidemia.
  • Review strategies for managing CVD risk in pregnant women or women who plan to become pregnant.

Session II: Ethical Dilemmas in Lipidology

  • Discuss ethical controversies in the practice of lipidology.

NLA Opening Session: Impact of Genetics on Clinical Practice

  • Evaluate the use of genetic testing to inform risk assessment and therapeutic decisions.
  • Explain the role of the genetic counselor in screening for genetic disorders.
  • Review challenges in the application of genomic testing into clinical practice.
  • Apply insight from human genetics to identify novel therapeutic targets.

Session III: Non-Alcoholic Fatty Liver Disease and Risk of Cardiovascular Disease: What Clinicians Need to Know

  • Identify appropriate lipid management for patients with non-alcoholic fatty liver disease.
  • Review appropriate diagnostic strategies in patients with non-alcoholic fatty liver disease.
  • Determine therapeutic options for the treatment of non-alcoholic fatty liver disease.

W. Virgil Brown Distinguished Achievement Award and Lectureship

  • Evaluate the management of patients with dyslipidemia.

Session IV: Imaging Atherosclerosis: What We Know and Gaps in Knowledge

  • Review the use of imaging modalities for cardiovascular risk assessment.

Session V: Let’s Talk About Sex…Hormones

  • Discuss the efficacy and safety of hormonal therapies in the management of dyslipidemia and cardiovascular risk.

Session VI: Prevention of Atherosclerotic Cardiovascular Disease in South Asians in the US

  • Recognize the risk factors and interconnection of early onset diabetes and ASCVD in South Asians.
  • Discuss epidemiology and risk profiles for dyslipidemia in South Asians in the United States.

Session VII: Ask the Magic Lipid Ball: An Interactive Audience Session

  • Appraise current and emerging pharmacologic management options for dyslipidemia.

Session VIII: Oral Poster Presentations

  • Critically appraise emerging research and its applications to daily clinical practice.

Special Joint Session Between EAS and NLA: Dyslipidemia Treatment in Light of the New Guidelines

  • Describe current guidelines for the management of dyslipidemia.

Session IX: Scientific Statements of the NLA

  • Review current literature of importance to the science and practice of clinical lipidology.

NLA Junior Faculty Research Award Presentation

  • Discuss the recent research impacting future management of patients with dyslipidemia.
Delete PROGRAM


SCIENTIFIC MEETINGS CO-CHAIRS

Christie M. Ballantyne, MD, FNLA

Committee Co-Chair
Professor of Medicine
Vice Chair of Research for the Department of Medicine
Chief, Section of Cardiovascular Research
Chief, Section of Cardiology
Department of Medicine
Baylor College of Medicine
Houston, TX

Anne C. Goldberg, MD, FACP, FNLA

Committee Co-Chair
President, Foundation of the NLA

Professor of Medicine
Washington University School of Medicine
St. Louis, MO



PROGRAM PLANNERS

Casey Elkins, DNP, MEd, NP-C, CLS, FNLA

Program Planner
Assistant Dean for Academic Affairs
Director, DNP Program
University of South Alabama
College of Nursing
Mobile, AL

Peter H. Jones, MD, FNLA

Program Planner
Associate Professor
Baylor College of Medicine
Houston, TX

Carol Kirkpatrick, PhD, RDN, MPH, CLS, FNLA

Program Planner
Director/Clinical Associate Professor
Wellness Center
Idaho State University
Kasiska Division of Health Sciences
Pocatello, ID

Ann M. Liebeskind, MD, FNLA

President, Midwest Chapter Lipid Association
Founder
Mobile Health Team Lipids Clinic
Neenah, WI
Clinical Adjunct Assistant Professor
University of Wisconsin
School of Medicine and Public Health
Madison, WI

Pamela B. Morris, MD, FNLA

Program Planner
Director, Preventive Cardiology
Co-Director, Women’s Heart Care
Medical University of South Carolina
Mt. Pleasant, SC

Alan T. Remaley, MD, PhD

Program Planner
Section Chief Lipoprotein Metabolism Laboratory
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, MD

Joseph J. Saseen, PharmD, CLS, FNLA

Program Planner
President, National Lipid Association

Professor and Vice Chair
Clinical & Academic Programs
Department of Clinical Pharmacy
University of Colorado Anschutz Medical Campus
Skaggs School of Pharmacy
Aurora, CO

Daniel E. Soffer, MD, FNLA

Program Planner
University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman Center for Advanced Medicine
Philadelphia, PA



FACULTY

Zahid Ahmad, MD

Associate Professor of Internal Medicine
Co-Director, Familial Hypercholesterolemia Clinic
UT Southwestern Medical Center
Dallas, TX

Christie M. Ballantyne, MD, FNLA

Committee Co-Chair
Professor of Medicine
Vice Chair of Research for the Department of Medicine
Chief, Section of Cardiovascular Research
Chief, Section of Cardiology
Department of Medicine
Baylor College of Medicine
Houston, TX

Eliot A. Brinton, MD, FNLA

President
Utah Lipid Center
Salt Lake City, UT

Emily E. Brown, MGC, CGC

Certified Genetic Counselor
Center for Inherited Heart Disease
Johns Hopkins University
Baltimore, MD

 

 

 

Matthew J. Budoff, MD

Professor of Medicine
UCLA School of Medicine
Program Director, Cardiology
Lundquist Institute
Torrance, CA

Alberico L. Catapano, PhD

Professor of Pharmacology
Director
Center of Epidemiology and Preventive Pharmacology
Director
Laboratory of Lipoproteins, Immunity and Atherosclerosis
Department of Pharmacological and Biomolecular Sciences Director
Center for the Study of Atherosclerosis
Bassini Hospital
University of Milan                           
Milan, Italy

 

Nihar R. Desai, MD, MPH

Associate Professor of Medicine
Yale School of Medicine
Associate Chief
Section of Cardiovascular Medicine
Yale New Haven Health System
New Haven, CT

G. Kevin Donovan, MD, MA

Director
Pellegrino Center for Clinical Bioethics
Professor of Pediatrics
Georgetown University Medical Center
Washington, DC

Eugenia Gianos, MD, FNLA

System Director
Cardiovascular Prevention
Northwell Health
Director
Women's Cardiovascular Program
Lenox Hill Hospital
Associate Professor of Cardiology
Hofstra School of Medicine
New York, NY

John R. Guyton, MD, FNLA

Professor of Medicine
Assistant Professor of Pathology
Department of Medicine
Duke University School of Medicine
Durham, NC

Alizah Hussain, MD

PGY4, Lipid and Atherosclerosis Fellow
Baylor College of Medicine
Houston, TX

Peter H. Jones, MD, FNLA

Program Planner
Associate Professor
Baylor College of Medicine
Houston, TX

Dinesh Kalra, MD

Director
Lipid Clinic and Advanced Cardiac Imaging
Division of Cardiology
Rush University Medical Center
Chicago, IL

Wahida Karmally, PhD, DrPH, RDN, CDE, CLS, FNLA

Columbia University
New York, NY

Joshua W. Knowles, MD

Assistant Professor
Cardiovascular Medicine and Cardiovascular Institute
Stanford University
Chief Research Advisor
The FH Foundation
Stanford, CA

Ann M. Liebeskind, MD, FNLA

President, Midwest Chapter Lipid Association
Founder
Mobile Health Team Lipids Clinic
Neenah, WI
Clinical Adjunct Assistant Professor
University of Wisconsin
School of Medicine and Public Health
Madison, WI

Pamela B. Morris, MD, FNLA

Program Planner
Director, Preventive Cardiology
Co-Director, Women’s Heart Care
Medical University of South Carolina
Mt. Pleasant, SC

Carl E. Orringer, MD, FNLA

Associate Professor of Clinical Medicine
Director
Preventive Cardiovascular Medicine
University of Miami Miller School of Medicine
Miami, FL

Elizabeth (Lisa) Phillips, BSPharm, PharmD

Associate Professor and Chair
Pharmacy Practice and Administration
St. John Fisher College
Wegmans School of Pharmacy
Rochester, NY

Maamoun Salam, MD

Assistant Professor of Medicine
Division of Endocrinology, Metabolism and Lipid  Research
Washington University
St. Louis, MO

Raul D. Santos, MD, MSc, PhD

President, International Atherosclerosis Society
Associate Professor, Cardiology
Director
Lipid Clinic Heart Institute
University of Sao Paulo Brazil
Researcher Hospital Israelita Albert Einstein
Sao Paulo, Brazil

Joseph J. Saseen, PharmD, CLS, FNLA

Program Planner
President, National Lipid Association

Professor and Vice Chair
Clinical & Academic Programs
Department of Clinical Pharmacy
University of Colorado Anschutz Medical Campus
Skaggs School of Pharmacy
Aurora, CO

James H. Stein, MD, FNLA

Robert Turell Professor in Cardiovascular Research
Director
Atherosclerosis Imaging Research Program
University of Wisconsin
School of Medicine and Public Health
Director
Preventive Cardiology
UW Health
Madison, WI

Nathan O. Stitziel, MD, PhD

Associate Professor of Medicine and Genetics
Director
Center for Cardiovascular Genetics
Washington University School of Medicine
St. Louis, MO

Pam R. Taub, MD

Director
Step Family Foundation Cardiovascular Rehabilitation and Wellness Center
Associate Professor of Medicine
Department of Cardiovascular Medicine
University of California, San Diego
La Jolla, CA

Jennifer L. Thompson, MD

Assistant Professor Obstetrics and Gynecology
Fellowship Program Director
Maternal Fetal Medicine
Vanderbilt University Medical Center
Nashville, TN

Lale Tokgözoğlu, MD

President, European Atherosclerosis Society
Professor of Cardiology
Hacettepe University
Ankara, Turkey

James A. Trippi, MD, FNLA

Director
Complex Cholesterol Center
Cardiometabolic Center
Ascension- St. Vincent Health
Indianapolis, IN

James A. Underberg, MD, MS, FNLA

Past- President, National Lipid Association
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for Prevention of Cardiovascular Disease
Director
Bellevue Hospital Lipid Clinic
New York, NY

Elaine M. Urbina, MD, MS

Director
Preventive Cardiology
Cincinnati Children's Hospital Medical Center
Cincinnati, OH

John M. Vierling, MD

Professor of Medicine and Surgery
Chief of Hepatology
Director of Advanced Liver Therapies
Baylor College of Medicine
Houston, TX

Krishnaswami Vijayaraghavan, MD, MS, FNLA

Executive Council Chair, National Lipid Association
Medical Director
CHF, Abrazo Health Network
Clinical Professor of Medicine
University of Arizona
Phoenix, AZ

Michael Wilkinson, MD

Assistant Professor of Medicine
Division of Cardiovascular Medicine
University of California, San Diego
La Jolla, CA

Don P. Wilson, MD, FNLA

Director
Pediatric CV Health and Risk Reduction
Cook Children’s Medical Center’
Fort Worth, TX



Register for 2020 Scientific Sessions

Registration Options






NLA Member Pricing
*Must be logged in


Main Session

December 10-12, 2020


Masters in Lipidology

December 3-4, 2020


Foundations of Lipidology

November 19-20, 2020


Non-Member Pricing


Main Session

December 10-12, 2020

OR

Join the NLA and save on registration

$195.00 NLA Member Applicaton + $299.00 Main Session Registration - $50.00 New Member Discount

Masters in Lipidology

December 3-4, 2020


Foundations of Lipidology

November 19-20, 2020


Trainee Pricing
*Must be logged in


Main Session

December 10-12, 2020


Masters in Lipidology

December 3-4, 2020


Foundations of Lipidology

November 19-20, 2020

$ 0.00


Interested in the Trainee Rate?


Enrolled in a graduate or postgraduate training program and want to attend at the Trainee Member rate?

Apply now for free





Disclaimer


Lipid Bucks: Lipid Bucks can be applied on the checkout page.

Registration: Online registration and payment must be received no later than December 9, 2020. By registering for this meeting, attendee understands and agrees that attendee’s name, city, and state may be shared with other attendees and exhibitors. By visiting the virtual exhibit hall, attendee understands, agrees and consents to the sharing of attendee’s contact information with the participating companies.

Photography: Photographs and/or video may be taken as part of the registered event. By registering for this event, you grant the National Lipid Association full rights to use the images resulting from the photography/video filming and any reproductions or adaptations of the images for promotional purposes. This may include (but is not limited to), the right to use them in print and online platforms, social media, press releases and other outlets.

Cancellation: Telephone cancellations will not be accepted. A written notice of cancellation must be received no later than November 10, 2020. There will be a $50 fee for all cancellations. There will be no refunds if cancelling within 30 days of the start of the meeting date.

Attendees who need special reasonable accommodations or who have special needs should contact the meeting organizers at 904-998-0854.